Skip to main content

FDA recall, , Moderate risk

DT MedTech Hintermann Series Talar Implant

The Hintermann Series Talar Implant, Left, Size 2 has incorrect packaging labeling a right implant device.

What happened

DT MedTech, LLC, of Mcminnville, Tennessee, recalled the Hintermann Series Talar Implant, Left, Size 2 REF 302112 after customer complaints found the ankle replacement system contained incorrect devices: left implant packaging and labeling bears a right implant device. The recall began March 24, 2026, and was added to the FDA's Enforcement Report on June 10, 2026.

The recalled product was distributed worldwide, with US nationwide distribution in the states of Arkansas, Arizona, California and Idaho, and in the countries of Peru and Korea. The recall involved 67 units.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its lot code matches.

  1. Hintermann Series Talar Implant, Left, Size 2 REF 302112

    Lot code
    • B095302112

Recall details

Company began the recall
Sold in

Worldwide - US Nationwide distribution in the states of California, Arkansas, Arizona, Idaho and the countries of PER, KOR.

Company
DT MedTech, LLCMcminnville, Tennessee
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98987
Recall number
Z-2399-2026
Quantity recalled
67 units

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)